TNYA
Tenaya Therapeutics, Inc.Company with tickers: TNYA
CIK
1858848
CUSIP
87990A106
Shares Outstanding
216,998,876
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $225,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $20,290,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Research & Development | $14,843,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-20,065,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-19,272,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-0.09 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-0.09 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |